Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Yondelis receives orphan drug status for soft tissue sarcoma

Oct. 14, 2004

Interim results of BrachySil phase IIa study in liver cancer patients

Oct. 14, 2004

Erbitux in phase III for NSCLC

Oct. 14, 2004

Simultaneous targeting of tumor proliferation and angiogenesis shows promising results in vivo

Oct. 14, 2004

Liposomal-encapsulated paclitaxel well tolerated in prostate cancer patients

Oct. 13, 2004

PI3K antagonist enhances radiation-induced vascular destruction in tumors

Oct. 13, 2004

Epothilone derivative promising in human gliomas and drug-resistant melanomas

Oct. 13, 2004

Combination therapy overcomes resistance of prostate cancer cells to apoptosis

Oct. 13, 2004

Takeda signs agreement to market Tavocept in U.S. and Canada

Oct. 13, 2004

Takeda presents metastin derivatives for cancer therapy and other uses

Oct. 13, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026